Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid plus oxytocin versus oxytocin alone for blood loss reduction during elective caesarean section
PACTR202605854303695Not yet recruiting
- Sponsor
- Ani Frank Onyeka
- Start
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Trial of tranexamic acid and oxytocin (2 arms), sponsored by Ani Frank Onyeka. Primary endpoint: Mean intraoperative blood loss. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
tranexamic acidoxytocin
Beyond the preview
Go deeper on PACTR202605854303695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605854303695.